Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia
β Scribed by Chen, Chen; Xu, Wei; Yang, Jing
- Book ID
- 126588599
- Publisher
- Informa plc
- Year
- 2014
- Tongue
- English
- Weight
- 341 KB
- Volume
- 56
- Category
- Article
- ISSN
- 1042-8194
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract As sensitization of leukemic cells with granulocyte colonyβstimulating factor (Gβcsf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of Gβcsf priming combined with lowβdose chemotherapy in patient
## Abstract ## Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (AraβC) and etoposide (VPβ16) (AV therapy) for those elderly AML patients